Anchiano Therapeutics Short Interest Ratio and Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.
-0.02 (-0.10 %)
(As of 05/7/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume385,699 shs
Average Volume3.15 million shs
Market Capitalization$147.14 million
P/E Ratio132.20
Dividend YieldN/A

Short Interest

Anchiano Therapeutics (NASDAQ:ANCN) Short Interest Data

Current Short Volume65,200 shares
Previous Short Volume190,200 shares
Change Vs. Previous Month-65.72%
Dollar Volume Sold Short$231,460.00
Short Interest Ratio / Days to Cover0.0
Last Record DateFebruary, 26 2021
Outstanding Shares7,360,000 shares
Percentage of Shares Shorted0.88%
Today's Trading Volume385,699 shares
Average Trading Volume3,145,648 shares
Today's Volume Vs. Average-87.74%

Short Interest Over Time

Anchiano Therapeutics (NASDAQ:ANCN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/26/202165,200 shares $231,460.00 -65.7%N/A0$3.55
2/12/2021190,200 shares $914,862.00 +2,370.1%N/A0.1$4.81
1/29/20217,700 shares $16,697.45 -84.0%N/A0$2.17
1/15/202148,200 shares $112,788.00 +18.1%N/A0$2.34
12/31/202040,800 shares $79,560.00 +112.5%N/A0$1.95
12/15/202019,200 shares $29,568.00 +910.5%N/A0$1.54
11/30/20201,900 shares $2,926.00 -84.7%N/A0$1.54
11/15/202012,400 shares $17,484.00 -79.4%N/A0$1.41
10/30/202060,100 shares $71,519.00 +526.0%N/A0.1$1.19
10/15/20209,600 shares $11,136.00 -57.3%N/A0$1.16
9/30/202022,500 shares $25,650.00 +97.4%N/A0.2$1.14
9/15/202011,400 shares $12,198.00 +35.7%N/A0.1$1.07
8/31/20208,400 shares $8,220.24 -56.0%N/A0.1$0.98
8/14/202019,100 shares $22,156.00 +76.9%N/A0.2$1.16
7/31/202010,800 shares $10,445.76 -49.3%N/A0.1$0.97
7/15/202021,300 shares $16,658.73 +19.7%N/A0.2$0.78
6/30/202017,800 shares $24,208.00 +24.5%N/A0.3$1.36
6/15/202014,300 shares $21,650.20 +186.0%N/A0.2$1.51
5/29/20205,000 shares $5,500.00 +42.9%N/A0.1$1.10
5/15/20203,500 shares $3,273.90 -75.7%N/A0.1$0.94
4/30/202014,400 shares $12,960.00 +2.9%N/A0.5$0.90
4/15/202014,000 shares $10,918.60 +3.7%N/A0.6$0.78
3/31/202013,500 shares $10,611.00 +62.7%N/A0.4$0.79
3/13/20208,300 shares $7,286.57 -20.2%N/A0.6$0.88
2/28/202010,400 shares $9,344.40 -21.8%N/A0.3$0.90

Anchiano Therapeutics (NASDAQ:ANCN) Short Interest FAQ

speech bubbles
speech bubbles

What is Anchiano Therapeutics' current short interest?

Short interest is the volume of Anchiano Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 26th, investors have sold 65,200 shares of ANCN short.

Is Anchiano Therapeutics' short interest increasing or decreasing?

Anchiano Therapeutics saw a drop in short interest in February. As of February 26th, there was short interest totaling 65,200 shares, a drop of 65.7% from the previous total of 190,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Anchiano Therapeutics' short interest compare to its competitors?

0.00% of Anchiano Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Anchiano Therapeutics: Rigel Pharmaceuticals, Inc. (0.00%), Albireo Pharma, Inc. (0.00%), Aldeyra Therapeutics, Inc (0.00%), Intercept Pharmaceuticals, Inc. (23.33%), Mirum Pharmaceuticals, Inc. (4.74%), Veru Inc. (2.60%), SIGA Technologies, Inc. (4.45%), Basilea Pharmaceutica AG (0.00%), Inventiva S.A. (0.47%), and CytomX Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.58 billion), Aon plc ($5.72 billion), Analog Devices, Inc. ($5.42 billion), Charter Communications, Inc. ($4.94 billion), Snap Inc. ($3.85 billion), Airbnb, Inc. ($2.46 billion), Discovery, Inc. ($2.34 billion), Futu Holdings Limited ($2.31 billion), The Kroger Co. ($2.05 billion), and Palo Alto Networks, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short Anchiano Therapeutics stock?

Short selling ANCN is an investing strategy that aims to generate trading profit from Anchiano Therapeutics as its price is falling. Anchiano Therapeutics' stock is trading down $0.02 today. To short Anchiano Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Anchiano Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Anchiano Therapeutics?

A short squeeze for Anchiano Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANCN, which in turn drives the price of the stock up even further.

How often is Anchiano Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANCN, twice per month. The most recent reporting period available is February, 26 2021.

This page was last updated on 5/10/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.